Concepts (101)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Acrolein | 3 | 2025 | 11 | 1.910 |
Why?
|
| Glioblastoma | 4 | 2025 | 331 | 1.640 |
Why?
|
| Colonic Neoplasms | 2 | 2025 | 252 | 1.390 |
Why?
|
| Hypoxia-Inducible Factor 1, alpha Subunit | 2 | 2025 | 89 | 1.140 |
Why?
|
| Glioma | 3 | 2025 | 479 | 0.980 |
Why?
|
| Extracellular Traps | 1 | 2025 | 8 | 0.960 |
Why?
|
| Thyroid Hormones | 1 | 2025 | 55 | 0.920 |
Why?
|
| Brain Neoplasms | 5 | 2025 | 1224 | 0.830 |
Why?
|
| Carrier Proteins | 1 | 2025 | 1011 | 0.650 |
Why?
|
| Membrane Proteins | 1 | 2025 | 1569 | 0.550 |
Why?
|
| Colorectal Neoplasms | 1 | 2022 | 622 | 0.490 |
Why?
|
| HSP90 Heat-Shock Proteins | 2 | 2025 | 39 | 0.420 |
Why?
|
| Neutrophils | 2 | 2025 | 349 | 0.370 |
Why?
|
| Reactive Oxygen Species | 2 | 2025 | 493 | 0.350 |
Why?
|
| Cell Line, Tumor | 2 | 2025 | 3497 | 0.280 |
Why?
|
| Gene Expression Regulation, Neoplastic | 2 | 2025 | 1931 | 0.280 |
Why?
|
| Glucose Transporter Type 1 | 1 | 2025 | 24 | 0.240 |
Why?
|
| HCT116 Cells | 1 | 2025 | 60 | 0.230 |
Why?
|
| Monocarboxylic Acid Transporters | 1 | 2025 | 35 | 0.230 |
Why?
|
| Symporters | 1 | 2025 | 73 | 0.220 |
Why?
|
| Oxidative Phosphorylation | 1 | 2025 | 126 | 0.220 |
Why?
|
| Glycolysis | 1 | 2025 | 167 | 0.220 |
Why?
|
| Interleukin-8 | 1 | 2025 | 203 | 0.220 |
Why?
|
| Tumor Microenvironment | 3 | 2023 | 628 | 0.220 |
Why?
|
| Mice, Nude | 1 | 2025 | 708 | 0.210 |
Why?
|
| Adaptation, Physiological | 1 | 2025 | 258 | 0.210 |
Why?
|
| Cell Movement | 2 | 2025 | 849 | 0.210 |
Why?
|
| Interleukin-6 | 1 | 2025 | 406 | 0.210 |
Why?
|
| Terphenyl Compounds | 1 | 2022 | 2 | 0.190 |
Why?
|
| Macrocyclic Compounds | 1 | 2022 | 13 | 0.190 |
Why?
|
| CRISPR-Cas Systems | 1 | 2025 | 277 | 0.190 |
Why?
|
| Receptors, Tumor Necrosis Factor | 1 | 2022 | 73 | 0.190 |
Why?
|
| Poly(ADP-ribose) Polymerase Inhibitors | 1 | 2022 | 37 | 0.190 |
Why?
|
| NF-E2-Related Factor 2 | 1 | 2022 | 101 | 0.180 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2023 | 288 | 0.170 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2023 | 477 | 0.170 |
Why?
|
| Antioxidants | 1 | 2022 | 321 | 0.160 |
Why?
|
| Substantia Nigra | 1 | 2020 | 35 | 0.160 |
Why?
|
| Spermidine | 1 | 2019 | 5 | 0.160 |
Why?
|
| Single-Chain Antibodies | 1 | 2020 | 36 | 0.160 |
Why?
|
| Acetyltransferases | 1 | 2019 | 72 | 0.160 |
Why?
|
| Corpus Striatum | 1 | 2020 | 90 | 0.150 |
Why?
|
| Disease Progression | 1 | 2025 | 2109 | 0.150 |
Why?
|
| alpha-Synuclein | 1 | 2020 | 123 | 0.150 |
Why?
|
| Cell Proliferation | 1 | 2025 | 2397 | 0.140 |
Why?
|
| Humans | 11 | 2025 | 126679 | 0.130 |
Why?
|
| Receptors, Prostaglandin E, EP4 Subtype | 1 | 2016 | 7 | 0.130 |
Why?
|
| Dinoprostone | 1 | 2016 | 67 | 0.130 |
Why?
|
| Membrane Microdomains | 1 | 2016 | 60 | 0.120 |
Why?
|
| Signal Transduction | 2 | 2019 | 4472 | 0.120 |
Why?
|
| Mammary Glands, Human | 1 | 2016 | 80 | 0.120 |
Why?
|
| Extracellular Vesicles | 1 | 2016 | 54 | 0.120 |
Why?
|
| Animals | 6 | 2025 | 33045 | 0.100 |
Why?
|
| Parkinson Disease | 1 | 2020 | 700 | 0.100 |
Why?
|
| Stem Cells | 1 | 2016 | 683 | 0.090 |
Why?
|
| Blood-Brain Barrier | 2 | 2023 | 139 | 0.090 |
Why?
|
| Stroke | 1 | 2019 | 1025 | 0.090 |
Why?
|
| Mice | 2 | 2025 | 17594 | 0.090 |
Why?
|
| Mutation | 1 | 2023 | 5939 | 0.080 |
Why?
|
| Rats | 3 | 2021 | 3387 | 0.080 |
Why?
|
| Chemoradiotherapy | 1 | 2023 | 118 | 0.050 |
Why?
|
| Speech | 1 | 2023 | 56 | 0.050 |
Why?
|
| Language | 1 | 2023 | 205 | 0.040 |
Why?
|
| Neuronavigation | 1 | 2021 | 8 | 0.040 |
Why?
|
| Microbubbles | 1 | 2021 | 8 | 0.040 |
Why?
|
| Brain Mapping | 1 | 2023 | 369 | 0.040 |
Why?
|
| Neurosurgical Procedures | 1 | 2023 | 297 | 0.040 |
Why?
|
| Drug Delivery Systems | 1 | 2021 | 204 | 0.040 |
Why?
|
| Immunization | 1 | 2021 | 300 | 0.040 |
Why?
|
| Pilot Projects | 1 | 2023 | 1398 | 0.040 |
Why?
|
| Dependovirus | 1 | 2020 | 144 | 0.040 |
Why?
|
| Brain | 2 | 2021 | 3037 | 0.040 |
Why?
|
| Enzyme Activation | 1 | 2019 | 577 | 0.040 |
Why?
|
| Glutathione | 1 | 2019 | 195 | 0.040 |
Why?
|
| Gene Transfer Techniques | 1 | 2020 | 336 | 0.040 |
Why?
|
| Down-Regulation | 1 | 2020 | 646 | 0.030 |
Why?
|
| HEK293 Cells | 1 | 2020 | 767 | 0.030 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2023 | 1234 | 0.030 |
Why?
|
| Prostaglandin-E Synthases | 1 | 2016 | 6 | 0.030 |
Why?
|
| Caveolae | 1 | 2016 | 9 | 0.030 |
Why?
|
| Cell Shape | 1 | 2016 | 70 | 0.030 |
Why?
|
| Spheroids, Cellular | 1 | 2016 | 58 | 0.030 |
Why?
|
| rab GTP-Binding Proteins | 1 | 2016 | 49 | 0.030 |
Why?
|
| Integrins | 1 | 2016 | 88 | 0.030 |
Why?
|
| Cyclooxygenase 2 | 1 | 2016 | 126 | 0.030 |
Why?
|
| Cell Adhesion | 1 | 2016 | 299 | 0.030 |
Why?
|
| Cells, Cultured | 1 | 2020 | 2893 | 0.030 |
Why?
|
| Cohort Studies | 1 | 2023 | 4953 | 0.030 |
Why?
|
| Aged | 2 | 2023 | 20321 | 0.030 |
Why?
|
| Prospective Studies | 1 | 2023 | 6203 | 0.020 |
Why?
|
| Antibodies, Neutralizing | 1 | 2016 | 496 | 0.020 |
Why?
|
| Epithelial Cells | 1 | 2016 | 870 | 0.020 |
Why?
|
| Cell Line | 1 | 2016 | 2560 | 0.020 |
Why?
|
| Middle Aged | 2 | 2023 | 27672 | 0.020 |
Why?
|
| Disease Models, Animal | 1 | 2020 | 4426 | 0.020 |
Why?
|
| Female | 3 | 2023 | 68275 | 0.020 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2021 | 3693 | 0.020 |
Why?
|
| Mice, Inbred C57BL | 1 | 2016 | 4502 | 0.020 |
Why?
|
| Biomarkers | 1 | 2016 | 3219 | 0.020 |
Why?
|
| Male | 2 | 2023 | 62490 | 0.010 |
Why?
|
| Adult | 1 | 2023 | 30379 | 0.010 |
Why?
|